An evaluation of the impact of a multidisciplinary team, in a single centre, on treatment and survival in patients with inoperable non-small-cell lung cancer

Br J Cancer. 2005 Oct 31;93(9):977-8. doi: 10.1038/sj.bjc.6602825.

Abstract

Treatment and survival of patients with inoperable Non-small-cell lung cancer in 1997 (n=117) and 2001 (n=126), before and after the introduction of a multidisciplinary team, was examined in a single centre. There were no differences in age, sex and extent of deprivation between the two years. However, in 2001, 23% of patients received chemotherapy treatment compared with 7% in 1997 (P<0.001). Median survival in 2001 was 6.6 months compared with 3.2 months in 1997 (P<0.001).

MeSH terms

  • Age Distribution
  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / mortality*
  • Combined Modality Therapy
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / mortality*
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Patient Care Team / organization & administration*
  • Prospective Studies
  • Retrospective Studies
  • Sex Distribution
  • Survival Rate

Substances

  • Antineoplastic Agents